A herpes virus peptide binds and sequesters proteins important for MYC activation in lymphoma cells, presenting a new viral strategy for treating undruggable MYC-dependent cancers.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.
